Shanghai Eye Study for Adults

Blindness,Visual Impairment, Refractive Error, Cataract, High Myopia, Aging Clinical Trial

— SESA  

Official title:

Shanghai Eye Study for Adults

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03455478
• Other study ID #: YFZX2018001
• Status: Recruiting
• Phase: N/A
• Start date: January 1, 2016
• Est. completion date: November 30, 2026

Study information

• Verified date: May 2022
• Source: Shanghai Eye Disease Prevention and Treatment Center
• Contact: Xun Xu, MD
• Phone: 8613386259538
• Email: drxuxun[@]tom.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Blindness and visual impairment severely impact the visual health and life quality of people, particularly the 2.566 million senior citizens aged at 65 and above in Shanghai. The main reason is uncorrected refractive error, of which, 62.1% can be solved through refractive correction. For this reason, the uncorrected refractive errors of 154,000 senior citizens in Shanghai can be taken as a priority among the public health issues to prevent blindness. Now, with the aim to reduce the prevalence rate of blindness and visual impairment, it is planned to establish a public health service mechanism in terms of refractive error screening and correction for the elderly by relying on Shanghai's three-level (city-district-community) eye diseases prevention network, using proper refractive correction technology, and moving related services forward to communities in order to screen, identity, and correct blindness and visual impairment caused by refractive errors as early as possible.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1000000
• Est. completion date: November 30, 2026
• Est. primary completion date: November 30, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 100 Years

Eligibility

Inclusion Criteria:

• shanghai residents aged =18 years old

Exclusion Criteria:

• cognitive and/or mobility disorders; non-shanghai residents; younger than 18 years old.

Related Conditions & MeSH terms

• Blindness
• Blindness,Visual Impairment, Refractive Error, Cataract, High Myopia, Aging
• Cataract
• Refractive Errors
• Vision Disorders
• Vision, Low

Intervention

Device:
• spectacles
dispending spectacles for uncorrected refractive error

Locations

Country	Name	City	State
China	Shanghai Eye Disease Prevention & Treatment Center	Shanghai	Shanghai

Sponsors (2)

Lead Sponsor	Collaborator
Shanghai Eye Disease Prevention and Treatment Center	Brien Holden Vision

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	best-corrected visual acuity (BCVA)	the prevalence of blindness and visual impairment	5 years
Primary	cataract surgery rate	cataract surgery rate of Shanghai older people	5 years
Primary	cataract surgery coverage rate	cataract surgery coverage rate of Shanghai cataract patients	5 years
Primary	visual impairment caused by high myopia	observing the rate of visual impairment caused by high myopia	5 years